What type of study is this?

This is a Multivariable Analysis study (also classified as: Observational).

September 10, 2025Translational Lung Cancer ResearchOpen Access

Assessing the prognosis of metastatic or recurrent non-small cell lung cancer in the era of modern systemic therapies: a multivariable analysis of 343 patients treated in Poland

View Full Paper

Ask AI

Bookmark

Authors

RSRafał SuwińskiNational Institute of Oncology MKMarzena KysiakThe Maria Sklodowska-Curie National Research Institute of Oncology BCBożena Cybulska-StopaWrocław University of Science and Technology

Discussion

Member takes

Implication

Multivariable analysis reveals key prognostic factors influencing overall survival in patients with metastatic non-small cell lung cancer undergoing systemic therapies.

Key Points

Key prognostic factors identified for patients with metastatic non-small cell lung cancer include T stage and hemoglobin concentration, influencing overall survival significantly.
In a cohort of 343 patients, treatment including immune checkpoint inhibitors yielded a median survival time of 1.57 years, compared to chemotherapy at 0.80 years.
Multivariable analysis demonstrated a strong link between performance status, lymphocyte/neutrophil ratio, and overall survival, pointing to their importance in treatment outcomes.
The study emphasizes prioritizing independent prognostic variables over treatment type when evaluating survival in metastatic non-small cell lung cancer patients.

Cite This Study

Suwiński et al. (2025) studied this question.

synapsesocial.com/papers/68c1a25354b1d3bfb60dcc92 https://doi.org/10.21037/tlcr-2025-299

View Full Paper

Ask AI

Bookmark

Implication

Multivariable analysis reveals key prognostic factors influencing overall survival in patients with metastatic non-small cell lung cancer undergoing systemic therapies.

Assessing the prognosis of metastatic or recurrent non-small cell lung cancer in the era of modern systemic therapies: a multivariable analysis of 343 patients treated in Poland

Discussion

Member takes

Implication

Key Points

Cite This Study

Assessing the prognosis of metastatic or recurrent non-small cell lung cancer in the era of modern systemic therapies: a multivariable analysis of 343 patients treated in Poland

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider